Lisanti Capital Growth LLC Takes Position in TransMedics Group, Inc. (NASDAQ:TMDX)

Lisanti Capital Growth LLC acquired a new position in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 109,435 shares of the company’s stock, valued at approximately $8,638,000. TransMedics Group makes up 2.0% […]

Related Keywords

United States ,Jamesr Tobin ,Piper Sandler ,York Mellon Corp ,Insider Activity At Transmedics Group ,Transmedics Group ,Eventide Asset Management ,Vanguard Group Inc ,Transmedics Group Inc ,Morgan Stanley ,News Ratings For Transmedics Group Daily ,Exchange Commission ,Sandhill Capital Partners ,Transmedics Group Trading ,Transmedics Group Profile ,Lisanti Capital Growth ,Canaccord Genuity Group ,Jpmorgan Chase Co ,Quarter For Transmedics Group ,Nasdaq ,Free Report ,Medics Group ,Capital Growth ,Asset Management ,Capital Partners ,New York Mellon Corp ,Genuity Group ,Get Free Report ,Director James ,Organ Care System ,Transmedics Group Daily ,Nasdaq Tmdx ,Tmdx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,